Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Eye-Tracking study seeks to uncover hidden attention clues in ADHD and autism

NCT ID NCT06885060

Knowledge-focused Sponsor: Elizabeth Kilbey Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how eye movements, specifically eye vergence (how eyes work together for depth perception), relate to attention in people with ADHD and autism. Researchers will use computer-based eye-tracking tasks with 200 children and adults to see if these eye patterns can help identify attention differences. The goal is to better understand these conditions, not to test a treatment or device.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Jan 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Individuals from the Southeast of England, who are able to travel to either New Malden or Beckenham to partake in the study.

Ages

6 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Clinical Groups: Patients currently undergoing or who have previously undergone an assessment for either ADHD and/or Autism at either the CAN centre or Dr Kilbey's private practice in Beckenham. * Control Group: Subjects without a diagnosis of either ADHD nor Autism, who show no traits of these conditions. * People of any gender/sex who are aged older than 6 years old. Exclusion Criteria: * Those with non-corrected vision - e.g. near-sightedness, far-sightedness, strabismus or nystagmus * Individuals with any other oculomotor deficiency, blindness or vision loss.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention-deficit/hyperactivity disorder (ADHD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

attention deficit hyperactivity disorder, inattentive type attention deficit-hyperactivity disorder autism autism spectrum disorder Impulsive Behavior Spasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Attention-deficit/hyperactivity disorder (ADHD) Autism spectrum disorder (ASD)

Contacts and locations

Locations

  • Braingaze SL

    Barcelona, Catalonia, 08302, Spain

  • Child and Adult Neurodevelopment Assessment Ltd

    New Malden, London, KT3 4BH, United Kingdom

  • The Dr Kilbey Practice

    Beckenham, London, BR3 5AA, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.